Zhou, Wei <br/><br/>
Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Oct 2019 
 - 109369 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2019.109369  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Brain Neoplasms--diagnosis<br/>Cell Line, Tumor<br/>Child<br/>Female<br/>Glioma--diagnosis<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--enzymology<br/>Platelet Endothelial Cell Adhesion Molecule-1--metabolism<br/>Prognosis<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Tissue Inhibitor of Metalloproteinase-2--metabolism<br/>Young Adult